Nurse-led program to help adults with cancer stay active during outpatient treatment
Official title: Promoting Physical Activity in Individuals With Cancer in an Oncology Day Clinic - Testing the Feasibility of the Implementation of a Physical Activity Concept Within an Interprofessional Team Led by Nurses OnkoMoveNurse - Proof of Concept
Run by St.Gallen University of Applied Sciences · NCT06999616 · Data updated 2026-11-12
This project will try a nurse-led program to help adults with cancer stay more physically active while they receive outpatient treatments.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | St.Gallen University of Applied Sciences Academic / other |
| Drugs / interventions | chemotherapy, immunotherapy |
| Locations | 1 site (Münsterlingen) |
| Status | Recruiting |
| Started | August 1, 2025 |
| Main results expected | March 30, 2026 |
| Study ends | August 31, 2026 |
| Registry record updated | December 10, 2025 |
| Trial ID | NCT06999616 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18) with a cancer diagnosis who receive at least three outpatient treatments at the Münsterlingen oncology day clinic and have sufficient German language skills are ideal candidates.
✕Probably not a fit
Patients who are pregnant (excluded), medically unable to be active, severely frail, unable to attend the Münsterlingen clinic for required visits, or who do not speak sufficient German may not receive benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This mixed-methods project implements OncoMoveNurse, a person-centered physical activity program led by nurses, in an outpatient oncology day clinic. Over 15 months the team will run implementation and evaluation phases and collect quantitative data from about 50 patients (June–September 2025) using validated patient-reported outcome measures with physical activity behavior as the primary outcome. Qualitative insights will be gathered via digital storytelling with two patients and two nurses plus a focus group of eight interprofessional team members to explore experiences and implementation barriers. The program is built around five components — a modular exercise catalogue, a safety protocol, a communication strategy, team orientation, and person-centeredness — aiming to integrate more activity into routine care.
Why it matters
Potential benefit: If successful, it could help patients maintain or increase activity during treatment, potentially reducing fatigue and improving overall well-being.
How similar studies have gone: Exercise interventions have demonstrated benefits for people with cancer, but nurse-led outpatient implementation programs like OncoMoveNurse are less extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. diagnosis of cancer, 2. at least three treatments at the oncology outpatient clinic in Münsterlingen during the study period, 3. aged ≥18 years, and 4. sufficient knowledge of German. Exclusion Criteria: * pregnancy
Where it's running
-
Spital Thurgau AG Münsterlingen
Münsterlingen, Switzerland Recruiting
Study contacts
- Principal investigator: Antje Koller, PhD — Eastern Switzerland University of Applied Sciences
- Study coordinator: Antje Koller, PhD
- Email: antje.koller@ost.ch
- Phone: +41 58 257 12 13
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Gait Changes in Breast Cancer Patients Receiving Chemotherapy
This study tests how chemotherapy affects walking and balance in women with breast cancer.
-
HR20013 for preventing nausea and vomiting in cancer patients receiving chemotherapy
This real-world study tests whether HR20013 helps prevent nausea and vomiting in adults with cancer who are getting chemotherapy.
-
Targeted Induction Therapy for Stage III Unresectable EGFR Mutant NSCLC
This trial tests a targeted induction approach using fumetinib with platinum-based chemotherapy and concurrent radiochemotherapy in adults with unresectable stage III EGFR-mutant NSCLC to see if this combo can improve outcomes before possible surgery.
-
Methylscape test in body fluids for multi-cancer detection in Colombia
A simple blood, urine, or saliva test called Methylscape is being tested to see if it can detect multiple cancers and identify where the signal is coming from, using people with cancer and healthy volunteers in Colombia.
-
VR-guided mindfulness for anxiety, sleep, comfort, and fatigue in women with breast cancer undergoing chemotherapy
This study tests whether a virtual reality–based mindfulness program can help women with breast cancer feel less anxious, sleep better, feel more comfortable, and have less fatigue during chemotherapy.
-
Ready for Safe Cancer Treatment (RESET): A comprehensive perioperative program for surgical patients
The RESET program tests a structured, multidisciplinary perioperative plan to improve safety and recovery for adults having planned cancer surgery and older adults having planned non cancer-related surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.